As of Feb 12
| +0.44 / +7.82%|
The 7 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +64.74% increase from the last price of 6.07.
The current consensus among 8 polled investment analysts is to Hold stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.